Literature DB >> 19229496

Molecular characterization and phylogenetic analysis of H3N2 human influenza A viruses in Cheongju, South Korea.

Yun Hee Baek1, Jeung Hyun Park, Young Jun Song, Min-Suk Song, Philippe Noriel Q Pascua, Yoon-Soo Hahn, Heon-Seok Han, Ok-Jun Lee, Ki-Soon Kim, Chun Kang, Young-Ki Choi.   

Abstract

To investigate the genetic characteristics of human influenza viruses circulating in Chungbuk province, we tested 510 clinical samples of nasopharyngeal suction from pediatric patients diagnosed with respiratory illness between June 2007 and June 2008. Genetic characterization of the HA genes of H3N2 isolates indicated the relative higher similarity to A/Virginia/04/07 (99.6%) rather than that of A/Wisconsin/67/2005 (98.4%), a Northern Hemisphere 2007-2008 vaccine strain, based on amino acid sequences. We found several altered amino acids at the H3 HA1 antigenic sites compared with the vaccine strain; K140I at site A, K158R at site B, and K173N (H471) or K173Q, and S262N at site E, but there was no antigenic shift among the H3N2 viruses. Interestingly, A/Cheongju/H383/08 and A/Cheongju/H407/08 isolates had single amino acid substitution at D151G on the catalytic site of the N2 NA while A/Cheongju/H412/08 and A/Cheongju/ H398/07 isolates had one amino acid deletion at residue 146. Furthermore, we found that 25% (3 out of 12 isolates) of the H3N2 subtype viruses had the amino acid substitution at position 31 on the M2 protein (Aspartic acid to Asparagine) and confirmed their drug-resistance by biological assays. Taken together, the results of this study demonstrated continuous evolutions of human H3N2 viruses by antigenic drift and also highlighted the need to closely monitor antigenic drug resistance in influenza A viruses to aid in the early detection of potentially pandemic strains, as well as underscore the need for new therapeutics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19229496     DOI: 10.1007/s12275-008-0207-y

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   3.422


  26 in total

1.  Incidence of amantadine-resistant influenza A viruses in sentinel surveillance sites and nursing homes in Niigata, Japan.

Authors:  H Masuda; H Suzuki; H Oshitani; R Saito; S Kawasaki; M Nishikawa; H Satoh
Journal:  Microbiol Immunol       Date:  2000       Impact factor: 1.955

2.  Long term trends in the evolution of H(3) HA1 human influenza type A.

Authors:  W M Fitch; R M Bush; C A Bender; N J Cox
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

3.  Evolutionary characterization of recent human H3N2 influenza A isolates from Japan and China: novel changes in the receptor binding domain.

Authors:  S Lindstrom; S Sugita; A Endo; M Ishida; P Huang; S H Xi; K Nerome
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

4.  Isolation of influenza C virus from pigs and experimental infection of pigs with influenza C virus.

Authors:  Y J Guo; F G Jin; P Wang; M Wang; J M Zhu
Journal:  J Gen Virol       Date:  1983-01       Impact factor: 3.891

5.  Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus.

Authors:  L J Mitnaul; M N Matrosovich; M R Castrucci; A B Tuzikov; N V Bovin; D Kobasa; Y Kawaoka
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  Site-directed mutagenesis of catalytic residues of influenza virus neuraminidase as an aid to drug design.

Authors:  A A Ghate; G M Air
Journal:  Eur J Biochem       Date:  1998-12-01

7.  The role of influenza A virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction.

Authors:  A Vines; K Wells; M Matrosovich; M R Castrucci; T Ito; Y Kawaoka
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

8.  Reassortants in recent human influenza A and B isolates from South East Asia and Oceania.

Authors:  I G Barr; N Komadina; A Hurt; R Shaw; C Durrant; P Iannello; C Tomasov; H Sjogren; A W Hampson
Journal:  Virus Res       Date:  2003-12       Impact factor: 3.303

9.  Development of multiplex rt-PCR assays for rapid detection and subtyping of influenza type A viruses from clinical specimens.

Authors:  Hee Kyoung Chang; Jeung Hyun Park; Min-Suk Song; Taek-Kyu Oh; Seok-Young Kim; Chul-Jung Kim; Hyunggee Kim; Moon-Hee Sung; Heon-Seok Han; Youn-Soo Hahn; Young-Ki Choi
Journal:  J Microbiol Biotechnol       Date:  2008-06       Impact factor: 2.351

10.  Influenza AH1N2 viruses, United Kingdom, 2001-02 influenza season.

Authors:  Joanna S Ellis; Adriana Alvarez-Aguero; Vicky Gregory; Yi Pu Lin; A Hay; Maria C Zambon
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883

View more
  6 in total

1.  Susceptibility of human H3N2 influenza virus to oseltamivir in South Korea, 2009-2011.

Authors:  Sehee Park; Jin Il Kim; Ilseob Lee; Sangmoo Lee; Min-Woong Hwang; Joon-Yong Bae; Jun Heo; Eun-Joo Lim; Won-Seok Seok; Hee Jin Cheong; Joon Young Song; Woo Joo Kim; Man-Seong Park
Journal:  J Microbiol       Date:  2012-12-30       Impact factor: 3.422

2.  Virulence and genetic compatibility of polymerase reassortant viruses derived from the pandemic (H1N1) 2009 influenza virus and circulating influenza A viruses.

Authors:  Min-Suk Song; Philippe Noriel Q Pascua; Jun Han Lee; Yun Hee Baek; Kuk Jin Park; Hyeok-il Kwon; Su-Jin Park; Chul-Joong Kim; Hyunggee Kim; Richard J Webby; Robert G Webster; Young Ki Choi
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

3.  Full genomic analysis of an influenza A (H1N2) virus identified during 2009 pandemic in Eastern India: evidence of reassortment event between co-circulating A(H1N1)pdm09 and A/Brisbane/10/2007-like H3N2 strains.

Authors:  Tapasi Roy Mukherjee; Anurodh S Agrawal; Sekhar Chakrabarti; Mamta Chawla-Sarkar
Journal:  Virol J       Date:  2012-10-11       Impact factor: 4.099

4.  Phylogenetic, molecular and drug-sensitivity analysis of HA and NA genes of human H3N2 influenza A viruses in Guangdong, China, 2007-2011.

Authors:  P Huang; L-J Liang; N-M Hou; X Zhang; W-Z Su; S-Y Yu; Y-H Zhang; J Wu; W Q Chen
Journal:  Epidemiol Infect       Date:  2012-07-25       Impact factor: 4.434

5.  Full Genome Characterization of Human Influenza A/H3N2 Isolates from Asian Countries Reveals a Rare Amantadine Resistance-Conferring Mutation and Novel PB1-F2 Polymorphisms.

Authors:  Hassan Zaraket; Hiroki Kondo; Akinobu Hibino; Ren Yagami; Takashi Odagiri; Nobuhiro Takemae; Ryota Tsunekuni; Takehiko Saito; Yi Yi Myint; Yadanar Kyaw; Khin Yi Oo; Htay Htay Tin; Nay Lin; Nguyen Phuong Anh; Nguyen Le Khanh Hang; Le Quynh Mai; Mohd R Hassan; Yugo Shobugawa; Julian Tang; Ghassan Dbaibo; Reiko Saito
Journal:  Front Microbiol       Date:  2016-03-07       Impact factor: 5.640

6.  A benchmark dataset of protein antigens for antigenicity measurement.

Authors:  Tianyi Qiu; Jingxuan Qiu; Yiyan Yang; Lu Zhang; Tiantian Mao; Xiaoyan Zhang; Jianqing Xu; Zhiwei Cao
Journal:  Sci Data       Date:  2020-07-06       Impact factor: 6.444

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.